Nocturnal Frontal Lobe Epilepsy vs Parasomnias

被引:0
作者
Christopher Derry
机构
[1] Western General Hospital,Edinburgh and South East Scotland Epilepsy Service, Department of Clinical Neurosciences
来源
Current Treatment Options in Neurology | 2012年 / 14卷
关键词
Epilepsy; Frontal lobe epilepsy; Nocturnal frontal lobe epilepsy; NFLE; ADNFLE; Parasomnia; NREM sleep; NREM arousal parasomnia; Sleepwalking; Somnambulism; Sleep terrors; Confusional arousals;
D O I
暂无
中图分类号
学科分类号
摘要
The diagnosis and treatment of nocturnal events can present significant challenges to the clinician. Correct diagnosis is the first step towards appropriate treatment, but may not be straightforward. In particular, non-rapid eye movement (NREM) arousal parasomnias, such as sleepwalking, sleep terrors, and confusional arousal can present in a similar fashion to nocturnal frontal lobe epilepsy (NFLE); dramatic and often bizarre behaviors from sleep are features of both conditions, and may result in diagnostic confusion. A careful clinical history, however, often enables accurate diagnosis, and the frontal lobe epilepsy and parasomnia (FLEP) scale, a validated questionnaire for the diagnosis of nocturnal events, can add diagnostic confidence. Recording of events on video-EEG-polysomnography is required if diagnostic doubt remains although is not always achievable, particularly if events are occurring infrequently. Treatments for NFLE and parasomnias are different, but lifestyle modification and treatment of coexisting sleep disorders (such as obstructive sleep apnoea) may have a role in both. In NFLE, medical treatment with antiepileptic drugs, particularly carbamazepine and topiramate, forms the mainstay of treatment; a small proportion of individuals with treatment-resistant seizures may benefit from epilepsy surgery. For parasomnias, reassurance and the removal of priming and precipitating factors is often sufficient. A minority of individuals will, however, need medical treatment, usually with benzodiazepines or tricyclic antidepressants. Unfortunately, there are few data on which to base treatment decisions in this area, with the evidence comprising predominantly case reports and case series. Well-designed studies, including randomised control trials, are needed and may require a multicentre approach.
引用
收藏
页码:451 / 463
页数:12
相关论文
共 217 条
[1]  
Provini F(1999)Nocturnal frontal lobe epilepsy. A clinical and polygraphic overview of 100 consecutive cases Brain 122 1017-1031
[2]  
Plazzi G(2009)NREM arousal parasomnias and their distinction from nocturnal frontal lobe epilepsy: a video EEG analysis Sleep 32 1637-1644
[3]  
Tinuper P(1995)Autosomal dominant nocturnal frontal lobe epilepsy. A distinctive clinical disorder Brain 118 61-73
[4]  
Derry C(2000)The wide clinical spectrum of nocturnal frontal lobe epilepsy Sleep Med Rev 4 375-386
[5]  
Harvey A(1980)Hereditary factors in sleepwalking and night terrors Br J Psychiatry 137 111-118
[6]  
Walker M(2003)HLA and genetic susceptibility to sleepwalking Mol Psychiatry 2003 114-117
[7]  
Scheffer IE(2011)Novel genetic findings in an extended family pedigree with sleepwalking Neurology 76 49-52
[8]  
Bhatia KP(2007)Factors that predispose, prime and precipitate NREM parasomnias in adults: clinical and forensic implications Sleep Med Rev 11 5-30
[9]  
Lopes-Cendes I(2005)Adult chronic sleepwalking and its treatment based on polysomnography Brain 125 1062-1069
[10]  
Provini F(2003)Sleepwalking and sleep terrors in prepubertal children: what triggers them? Pediatrics 111 17-25